#JPM22: 4 top R&D chiefs discuss the key forces reshaping biopharma

On Tuesday I had a chance to sit down with 4 top R&D chiefs of some of the biggest organizations in the industry. There’s no question that the pandemic has been reshaping R&D, and I wanted to talk about the internal and external forces they’re experiencing that are continuing...

Click to view original post